19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

LS48 Availability of Structured Data for Clinical Study Protocols after Implementing ICH M11

Session Chair(s)

Hiroshi Matsuzawa, MSc

• Clinical Development
• Astellas Pharma Inc., Japan

Hajime Osawa

• Medical Writing 1G, Biometrics Dept.
• Chugai Pharmaceutical Co., Ltd., Japan

Speaker(s)

Manabu Inoue

• Associate Director, PV IT/Data management, Japan Pharmacovigilance
• MSD K.K., Japan

Niklas Jänich, PhD

• Head of Global Labeling Operations & Digitization
• Boehringer Ingelheim International GmbH, Germany